From the publishers of JADPRO

Metastatic HER2-Positive Breast Cancer Resource Center

Advertisement
Videos
Interview With Jame Abraham, MD: Metastatic HER2+ Breast Cancer Data at ASCO 2023
Interview With Kelley D. Mayden, DNP, APRN-FNP, AOCNP: Managing Side Effects Associated With HER2-Targeted Therapy
Interview With Michelle Melisko, MD: Brain Metastases in HER2+ Breast Cancer
Interview With Kristina Byers, PharmD, BCOP: Trastuzumab Deruxtecan in the Treatment of HER2+ Breast Cancer
Interview With John W. Park, MD: History of Metastatic HER2+ Breast Cancer Diagnosis and Treatment
Advertisement
Case Studies

ERBB2 Mutation in HER2-Nonamplified Breast Cancer

Managing Cardiotoxicity Associated With HER2-Targeted Therapy

ER+/PR+ HER2+ Breast Cancer With Brain Metastases

Advertisement
Quizzes
Test your knowledge on managing cardiotoxicity associated with HER2-targeted therapy
Test your knowledge of brain metastases in the HER2+ breast cancer setting
Test your knowledge on second-line treatment and side-effect management in mHER2+ breast cancer